Pricing
  1. US-listed companies
  2. EAGLE PHARMACEUTICALS, INC.
  3. Financials
  4. Operating income

EAGLE PHARMACEUTICALS, INC.【EGRX】

Market cap
$14.29K
P/E ratio
SummaryFinancials
Period EndOperating income (Million USD)YoY (%)
Dec 31, 202281+2823.80%
Dec 31, 20213-91.60%
Dec 31, 202033+51.06%
Dec 31, 201922-40.42%
Dec 31, 201837-50.51%
Dec 31, 201774+38.69%
Dec 31, 201653+1984.02%
Dec 31, 20153-113.65%
Sep 30, 2014-19

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)